Lower diurnal HPA-axis activity in male hypertensive and coronary heart disease patients predicts future CHD risk

BackgroundCoronary heart disease (CHD) and its major risk factor hypertension have both been associated with altered activity of the hypothalamus-pituitary-adrenal (HPA)-axis but the biological mechanisms underlying prospective associations with adverse disease outcomes are unclear. We investigated...

Full description

Bibliographic Details
Main Authors: Cathy Degroote, Roland von Känel, Livia Thomas, Claudia Zuccarella-Hackl, Nadine Messerli-Bürgy, Hugo Saner, Roland Wiest, Petra H. Wirtz
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1080938/full
_version_ 1827993998920253440
author Cathy Degroote
Roland von Känel
Livia Thomas
Livia Thomas
Claudia Zuccarella-Hackl
Claudia Zuccarella-Hackl
Nadine Messerli-Bürgy
Hugo Saner
Roland Wiest
Petra H. Wirtz
Petra H. Wirtz
Petra H. Wirtz
author_facet Cathy Degroote
Roland von Känel
Livia Thomas
Livia Thomas
Claudia Zuccarella-Hackl
Claudia Zuccarella-Hackl
Nadine Messerli-Bürgy
Hugo Saner
Roland Wiest
Petra H. Wirtz
Petra H. Wirtz
Petra H. Wirtz
author_sort Cathy Degroote
collection DOAJ
description BackgroundCoronary heart disease (CHD) and its major risk factor hypertension have both been associated with altered activity of the hypothalamus-pituitary-adrenal (HPA)-axis but the biological mechanisms underlying prospective associations with adverse disease outcomes are unclear. We investigated diurnal HPA-axis activity in CHD-patients, hypertensive (HT) and healthy normotensive men (NT) and tested for prospective associations with biological CHD risk factors.MethodsEighty-three male CHD-patients, 54 HT and 54 NT men repeatedly measured salivary cortisol over two consecutive days. Prospective CHD risk was assessed by changes between baseline and follow-up in the prothrombotic factors D-dimer and fibrinogen, the pro-inflammatory measures interleukin (IL)-6, tumor necrosis factor-alpha (TNF-α), and acute phase protein C-reactive protein (CRP), as well as blood lipids in terms of total cholesterol (tChol)/high-density-lipoprotein cholesterol (HDL)-ratio. We aggregated coagulation and inflammatory measures to respective indices.ResultsThe groups differed in repeated daytime cortisol (dayCort) secretion (p=.005,η2p=.03,f=0.18) and cortisol awakening response (CAR) (p=.006,η2p=.03,f=0.18), with similarly lower overall dayCort and CAR in CHD-patients and HT, as compared to NT. The groups differed further in cortisol at awakening (p=.015,η2p=.04,f=0.20) with highest levels in HT (p´s≤.050), and in diurnal slope between waking and evening cortisol (p=.033,η2p=.04,f=0.20) with steepest slopes in HT (p´s≤.039), although in part not independent of confounders. Lower aggregated dayCort and CAR in terms of area-under-the-curve (AUC) independently predicted increases in future overall CHD risk (AUCdayCort: p=.021,η2p=.10,f=0.33;AUCCAR: p=.028,η2p=.09,f=0.31) 3.00 ± 0.06(SEM) years later, with risk prediction most pronounced in fibrinogen (AUCdayCort: p=.017,ΔR2= 0.12;AUCCAR: p=.082).ConclusionWe found evidence for an HPA-axis hypoactivity in CHD and HT with lower diurnal HPA-axis activity predicting increases in cardiovascular risk as evidenced by increases in circulating levels of biomarkers of atherothrombotic risk. Down-regulation of basal HPA-axis activity may contribute to the pathogenesis of atherosclerosis and thrombosis in CHD via effects on coagulation.
first_indexed 2024-04-10T04:33:47Z
format Article
id doaj.art-549be2fcab2b418caa89a138d64347f1
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-10T04:33:47Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-549be2fcab2b418caa89a138d64347f12023-03-10T05:16:21ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-03-011410.3389/fendo.2023.10809381080938Lower diurnal HPA-axis activity in male hypertensive and coronary heart disease patients predicts future CHD riskCathy Degroote0Roland von Känel1Livia Thomas2Livia Thomas3Claudia Zuccarella-Hackl4Claudia Zuccarella-Hackl5Nadine Messerli-Bürgy6Hugo Saner7Roland Wiest8Petra H. Wirtz9Petra H. Wirtz10Petra H. Wirtz11Biological Work and Health Psychology, University of Konstanz, Konstanz, GermanyDepartment of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandBiological Work and Health Psychology, University of Konstanz, Konstanz, GermanyDepartment of Psychology, University of Bern, Bern, SwitzerlandDepartment of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Psychology, University of Bern, Bern, SwitzerlandInstitute of Psychology, University of Lausanne, Lausanne, SwitzerlandInstitute for Social and Preventive Medicine, University of Bern, Bern, SwitzerlandSupport Center of Advanced Neuroimaging, Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, University of Bern, Bern, SwitzerlandBiological Work and Health Psychology, University of Konstanz, Konstanz, GermanyDepartment of Psychology, University of Bern, Bern, SwitzerlandCentre for the Advanced Study of Collective Behaviour, University of Konstanz, Konstanz, GermanyBackgroundCoronary heart disease (CHD) and its major risk factor hypertension have both been associated with altered activity of the hypothalamus-pituitary-adrenal (HPA)-axis but the biological mechanisms underlying prospective associations with adverse disease outcomes are unclear. We investigated diurnal HPA-axis activity in CHD-patients, hypertensive (HT) and healthy normotensive men (NT) and tested for prospective associations with biological CHD risk factors.MethodsEighty-three male CHD-patients, 54 HT and 54 NT men repeatedly measured salivary cortisol over two consecutive days. Prospective CHD risk was assessed by changes between baseline and follow-up in the prothrombotic factors D-dimer and fibrinogen, the pro-inflammatory measures interleukin (IL)-6, tumor necrosis factor-alpha (TNF-α), and acute phase protein C-reactive protein (CRP), as well as blood lipids in terms of total cholesterol (tChol)/high-density-lipoprotein cholesterol (HDL)-ratio. We aggregated coagulation and inflammatory measures to respective indices.ResultsThe groups differed in repeated daytime cortisol (dayCort) secretion (p=.005,η2p=.03,f=0.18) and cortisol awakening response (CAR) (p=.006,η2p=.03,f=0.18), with similarly lower overall dayCort and CAR in CHD-patients and HT, as compared to NT. The groups differed further in cortisol at awakening (p=.015,η2p=.04,f=0.20) with highest levels in HT (p´s≤.050), and in diurnal slope between waking and evening cortisol (p=.033,η2p=.04,f=0.20) with steepest slopes in HT (p´s≤.039), although in part not independent of confounders. Lower aggregated dayCort and CAR in terms of area-under-the-curve (AUC) independently predicted increases in future overall CHD risk (AUCdayCort: p=.021,η2p=.10,f=0.33;AUCCAR: p=.028,η2p=.09,f=0.31) 3.00 ± 0.06(SEM) years later, with risk prediction most pronounced in fibrinogen (AUCdayCort: p=.017,ΔR2= 0.12;AUCCAR: p=.082).ConclusionWe found evidence for an HPA-axis hypoactivity in CHD and HT with lower diurnal HPA-axis activity predicting increases in cardiovascular risk as evidenced by increases in circulating levels of biomarkers of atherothrombotic risk. Down-regulation of basal HPA-axis activity may contribute to the pathogenesis of atherosclerosis and thrombosis in CHD via effects on coagulation.https://www.frontiersin.org/articles/10.3389/fendo.2023.1080938/fullHPA-axiscortisolcoronary heart diseasehypertensioncoagulation
spellingShingle Cathy Degroote
Roland von Känel
Livia Thomas
Livia Thomas
Claudia Zuccarella-Hackl
Claudia Zuccarella-Hackl
Nadine Messerli-Bürgy
Hugo Saner
Roland Wiest
Petra H. Wirtz
Petra H. Wirtz
Petra H. Wirtz
Lower diurnal HPA-axis activity in male hypertensive and coronary heart disease patients predicts future CHD risk
Frontiers in Endocrinology
HPA-axis
cortisol
coronary heart disease
hypertension
coagulation
title Lower diurnal HPA-axis activity in male hypertensive and coronary heart disease patients predicts future CHD risk
title_full Lower diurnal HPA-axis activity in male hypertensive and coronary heart disease patients predicts future CHD risk
title_fullStr Lower diurnal HPA-axis activity in male hypertensive and coronary heart disease patients predicts future CHD risk
title_full_unstemmed Lower diurnal HPA-axis activity in male hypertensive and coronary heart disease patients predicts future CHD risk
title_short Lower diurnal HPA-axis activity in male hypertensive and coronary heart disease patients predicts future CHD risk
title_sort lower diurnal hpa axis activity in male hypertensive and coronary heart disease patients predicts future chd risk
topic HPA-axis
cortisol
coronary heart disease
hypertension
coagulation
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1080938/full
work_keys_str_mv AT cathydegroote lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT rolandvonkanel lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT liviathomas lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT liviathomas lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT claudiazuccarellahackl lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT claudiazuccarellahackl lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT nadinemesserliburgy lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT hugosaner lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT rolandwiest lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT petrahwirtz lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT petrahwirtz lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk
AT petrahwirtz lowerdiurnalhpaaxisactivityinmalehypertensiveandcoronaryheartdiseasepatientspredictsfuturechdrisk